$PTPI SEC Filings

Filed On	Filing
30 Sep 2026	8-K: Bankruptcy or Receivership; Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement +1 more On September 30, 2026, Petros Pharmaceuticals, Inc. (the “Company”) entered into a General Assignment for the Benefit of Creditors (the “Assignment”), pursuant to California law, in which it assigned all of its right, title, and interest...
13 Aug 2026	10-Q
25 Jun 2026	Form 3: Weinstein Robert, Chief Accounting Officer Holds 636,004 shares of Common stock
18 Jun 2026	8-K: Departure/Election of Directors or Officers; Compensation
08 Jun 2026	Form 4: Walker Wayne Remell, Director Received 375,000 shares as a grant or award
05 Jun 2026	Form 4: Boctor Fady, See Remarks Received 375,000 shares as a grant or award
05 Jun 2026	Form 4: Bernstein Bruce, Director Received 1,875,000 shares as a grant or award
05 Jun 2026	Form 4: Silverman Joshua, Director Received 4,375,000 shares as a grant or award
05 Jun 2026	8-K: Departure/Election of Directors or Officers; Compensation
13 May 2026	10-Q
15 Apr 2026	10-K
31 Mar 2026	NT 10-K
17 Feb 2026	SCHEDULE 13G/A
06 Jan 2026	Form 4: Boctor Fady, See Remarks Received 500,000 shares as a grant or award
02 Jan 2026	Form 4: Silverman Joshua, Director Received 4,375,000 shares as a grant or award
02 Jan 2026	Form 4: Walker Wayne Remell, Director Received 500,000 shares as a grant or award
02 Jan 2026	Form 4: Bernstein Bruce, Director Received 1,875,000 shares as a grant or award
02 Jan 2026	8-K: Departure/Election of Directors or Officers; Compensation
20 Nov 2025	25-NSE
13 Nov 2025	10-Q

Comments